Harpreet S. Bajaj

Also affiliated with University of Ottawa, Brampton Civic Hospital, LMC Diabetes & Endocrinology (Canada), Çevre, Şehircilik ve İklim Değişikliği Bakanlığı

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Primary and Secondary Cardiovascular and Kidney Prevention With Canagliflozin: Insights From the CANVAS Program and CREDENCE Trial”.

Primary and Secondary Cardiovascular and Kidney Prevention With Canagliflozin: Insights From the CANVAS Program and CREDENCE Trial

Journal of the American Heart Association(2024)10.1161/jaha.123.031586

N/A

0.405DataRank · unranked

7 citations

Amir Razaghizad, Abdulaziz Joury, Adeera Levin, Harpreet S. Bajaj, G.B. John Mancini +9 more

Continuous Glucose Monitoring–Based Metrics and Hypoglycemia Duration in Insulin-Experienced Individuals With Long-standing Type 2 Diabetes Switched From a Daily Basal Insulin to Once-Weekly Insulin Icodec: Post Hoc Analysis of ONWARDS 2 and ONWARDS 4

Diabetes Care(2024)10.2337/dc23-2136

N/A

0DataRank · unranked

21 citations

Björg Ásbjörnsdóttir, Lisbeth Carstensen, Christian Laugesen, Chantal Mathieu, Athena Philis‐Tsimikas +2 more

Impact of Canagliflozin on Kidney and Cardiovascular Outcomes by Type 2 Diabetes Duration: A Pooled Analysis of the CANVAS Program and CREDENCE Trials

Diabetes Care(2024)10.2337/dc23-1450

N/A

0DataRank · unranked

12 citations

David M. Charytan, Harpreet S. Bajaj, Adeera Levin, Navdeep Tangri, April Slee +6 more